Literature DB >> 34985998

Antiviral CD19+CD27+ Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpesvirus Infection.

Nisha R Dhanushkodi1, Swayam Prakash1, Ruchi Srivastava1, Pierre-Gregoire A Coulon1, Danielle Arellano1, Rayomand V Kapadia1, Raian Fahim1, Berfin Suzer1, Leila Jamal1, Hawa Vahed2, Lbachir BenMohamed1,3,2,4.   

Abstract

Reactivation of herpes simplex virus 1 (HSV-1) from latently infected neurons of the trigeminal ganglia (TG) leads to blinding recurrent herpetic disease in symptomatic (SYMP) individuals. Although the role of T cells in herpes immunity seen in asymptomatic (ASYMP) individuals is heavily explored, the role of B cells is less investigated. In the present study, we evaluated whether B cells are associated with protective immunity against recurrent ocular herpes. The frequencies of circulating HSV-specific memory B cells and of memory follicular helper T cells (CD4+ Tfh cells), which help B cells produce antibodies, were compared between HSV-1-infected SYMP and ASYMP individuals. The levels of IgG/IgA and neutralizing antibodies were compared in SYMP and ASYMP individuals. We found that (i) the ASYMP individuals had increased frequencies of HSV-specific CD19+CD27+ memory B cells, and (ii) high frequencies of HSV-specific switched IgG+CD19+CD27+ memory B cells detected in ASYMP individuals were directly proportional to high frequencies of CD45R0+CXCR5+CD4+ memory Tfh cells. However, no differences were detected in the level of HSV-specific IgG/IgA antibodies in SYMP and ASYMP individuals. Using the UV-B-induced HSV-1 reactivation mouse model, we found increased frequencies of HSV-specific antibody-secreting plasma HSV-1 gD+CD138+ B cells within the TG and circulation of ASYMP mice compared to those of SYMP mice. In contrast, no significant differences in the frequencies of B cells were found in the cornea, spleen, and bone-marrow. Our findings suggest that circulating antibody-producing HSV-specific memory B cells recruited locally to the TG may contribute to protection from symptomatic recurrent ocular herpes. IMPORTANCE Reactivation of herpes simplex virus 1 (HSV-1) from latently infected neurons of the trigeminal ganglia (TG) leads to blinding recurrent herpetic disease in symptomatic (SYMP) individuals. Although the role of T cells in herpes immunity against blinding recurrent herpetic disease is heavily explored, the role of B cells is less investigated. In the present study, we found that in both asymptomatic (ASYMP) individuals and ASYMP mice, there were increased frequencies of HSV-specific memory B cells that were directly proportional to high frequencies of memory Tfh cells. Moreover, following UV-B-induced reactivation, we found increased frequencies of HSV-specific antibody-secreting plasma B cells within the TG and circulation of ASYMP mice compared to those of SYMP mice. Our findings suggest that circulating antibody-producing HSV-specific memory B cells recruited locally to the TG may contribute to protection from recurrent ocular herpes.

Entities:  

Keywords:  B memory cells; asymptomatic herpes; ocular herpes; plasma cells; virus-specific B cell

Mesh:

Substances:

Year:  2022        PMID: 34985998      PMCID: PMC8906405          DOI: 10.1128/jvi.02057-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  42 in total

Review 1.  Modularity in the TNF-receptor family.

Authors:  J H Naismith; S R Sprang
Journal:  Trends Biochem Sci       Date:  1998-02       Impact factor: 13.807

2.  Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.

Authors:  Tina M Cairns; Zhen-Yu Huang; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Anna Wald; Claude Krummenacher; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.

Authors:  G J Mertz; O Schmidt; J L Jourden; M E Guinan; M L Remington; A Fahnlander; C Winter; K K Holmes; L Corey
Journal:  Sex Transm Dis       Date:  1985 Jan-Mar       Impact factor: 2.830

5.  A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.

Authors:  Clare Burn; Natalie Ramsey; Scott J Garforth; Steven Almo; William R Jacobs; Betsy C Herold
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

6.  Cutting Edge: IL-10 Is Essential for the Generation of Germinal Center B Cell Responses and Anti-Plasmodium Humoral Immunity.

Authors:  Jenna J Guthmiller; Amy C Graham; Ryan A Zander; Rosemary L Pope; Noah S Butler
Journal:  J Immunol       Date:  2016-12-09       Impact factor: 5.422

7.  Ocular herpes simplex virus infection is diminished by depletion of B lymphocytes.

Authors:  C Jordan; S Baron; F Dianzani; J Barber; G J Stanton
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

8.  Cell entry mechanisms of HSV: what we have learned in recent years.

Authors:  Alex M Agelidis; Deepak Shukla
Journal:  Future Virol       Date:  2015-10-01       Impact factor: 1.831

9.  Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73+CD45RAhighCCR7lowCD8+ TEMRA and CD73+CD45RAlowCCR7lowCD8+ TEM Cells Are Associated with Asymptomatic Ocular Herpes.

Authors:  Ruchi Srivastava; Pierre-Grégoire Coulon; Soumyabrata Roy; Sravya Chilukuri; Sumit Garg; Lbachir BenMohamed
Journal:  J Immunol       Date:  2018-09-10       Impact factor: 5.422

Review 10.  Techniques to Study Antigen-Specific B Cell Responses.

Authors:  Jim Boonyaratanakornkit; Justin J Taylor
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

View more
  2 in total

1.  HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.

Authors:  Grzegorz B Gmyrek; Amanda N Berube; Virginie H Sjoelund; Daniel J J Carr
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

Review 2.  Cytokines and chemokines: The vital role they play in herpes simplex virus mucosal immunology.

Authors:  Jacinta B Smith; Jason J Herbert; Naomi R Truong; Anthony L Cunningham
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.